ROLE OF EPO IN THE ANGIOGENIC ACTIVITY OF BONE MARROW ENDOTHELIAL CELLS OF MGUS AND MULTIPLE MYELOMA PATIENTS

被引：0
|
作者：
Ribatti, D. [1 ]
Nico, B. [1 ]
机构：
[1] Univ Bari, Sch Med, Dept Basic Sci Neurosci & Sensory Organs, Bari, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1938
引用
收藏
页码：779 / 780
页数：2
相关论文
共 50 条
  • [31] Myeloma cells and bone marrow osteoblast interactions: Role in the development of osteolytic lesions in multiple myeloma
    Giuliani, Nicola
    Rizzoli, Vittorio
    LEUKEMIA & LYMPHOMA, 2007, 48 (12) : 2323 - 2329
  • [32] Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression
    Maiso, Patricia
    Mogollon, Pedro
    Ocio, Enrique M.
    Garayoa, Mercedes
    CANCERS, 2021, 13 (11)
  • [33] Bone marrow fibrosis in patients with multiple myeloma
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 257 - 258
  • [34] Transcriptome Alterations of Prospectively Isolated Bone Marrow Stromal Cells Provide Potential Cues to MGUS and Multiple Myeloma Pathobiology
    Zacharaki, Dimitra
    Ghazanfari, Roshanak
    Li, Hongzhe
    Lim, Hooi Ching
    Von Palffy, Sofia
    Soneji, Shamit
    Fioretos, Thoas
    Scheding, Stefan
    BLOOD, 2017, 130
  • [35] 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS
    Giovanella, Luca
    Taborelli, Monica
    Ceriani, Luca
    Zucca, Emanuele
    Cavalli, Franco
    Delaloye, Angelika Bischof
    NUCLEAR MEDICINE COMMUNICATIONS, 2008, 29 (06) : 535 - 541
  • [36] Alterations in bone marrow metabolism are an early and consistent feature during the development of MGUS and multiple myeloma
    C Ludwig
    D S Williams
    D B Bartlett
    S J Essex
    G McNee
    J W Allwood
    E Jewell
    A Barkhuisen
    H Parry
    S Anandram
    P Nicolson
    C Gardener
    F Seymour
    S Basu
    W B Dunn
    P A H Moss
    G Pratt
    D A Tennant
    Blood Cancer Journal, 2015, 5 : e359 - e359
  • [37] Alterations in bone marrow metabolism are an early and consistent feature during the development of MGUS and multiple myeloma
    Ludwig, C.
    Williams, D. S.
    Bartlett, D. B.
    Essex, S. J.
    McNee, G.
    Allwood, J. W.
    Jewell, E.
    Barkhuisen, A.
    Parry, H.
    Anandram, S.
    Nicolson, P.
    Gardener, C.
    Seymour, F.
    Basu, S.
    Dunn, W. B.
    Moss, P. A. H.
    Pratt, G.
    Tennant, D. A.
    BLOOD CANCER JOURNAL, 2015, 5 : e359 - e359
  • [38] Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents
    Cibeira, M. Teresa
    Rozman, Maria
    Segarra, Marta
    Lozano, Esther
    Rosinol, Laura
    Cid, Maria C.
    Filella, Xavier
    Blade, Joan
    CYTOKINE, 2008, 41 (03) : 244 - 253
  • [39] Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients
    Zdzisinska, Barbara
    Wejksza, Katarzyna
    Walter-Croneck, Adam
    Turski, Waldemar A.
    Kandefer-Szerszen, Martyna
    LEUKEMIA RESEARCH, 2010, 34 (01) : 38 - 45
  • [40] Angiogenic factor levels in bone marrow and serum of multiple myeloma patients are not applicable to predict response to chemotherapy
    Vadasz, Gy.
    Radvanyi, G.
    Tarkanyi, I.
    Barath, S.
    Udvardy, M.
    BLOOD REVIEWS, 2007, 21 : S128 - S128
12345